Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA
Clinical trial NCT02607553 · COMPLETED
Trial details
- NCT number
- NCT02607553
- Sponsor
- GenSpera, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.